Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06492148

Myofascial Release Technique in Women With Primary Dysmenorrhea

It has been found that women with dysmenorrhea have active trigger points, particularly in the rectus abdominis, oblique abdominal muscles, quadratus lumborum, and paraspinal muscles. The myofascial release technique is a widely used manual therapy method characterized by the application of low-load, long-duration mechanical forces to manipulate the myofascial complex. This technique aims to restore optimal length, alleviate pain, and improve function. This study aims to examine the effect of the myofascial release technique on central sensitization, myofascial trigger points, and menstrual symptoms in women with primary dysmenorrhea.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Gazi University

Ankara, 06530, Turkey (Türkiye)

Location status: Recruiting

Location contact

Beyza Yazgan Dagli

CONTACT

[email protected]

Beyza Yazgan Dagli

PRINCIPAL_INVESTIGATOR

Sevim B Olmez

PRINCIPAL_INVESTIGATOR

Zeynep B Alkan

PRINCIPAL_INVESTIGATOR

Zeynep Hazar Kanık

PRINCIPAL_INVESTIGATOR

About this study

During the evaluation period, the participants' musculoskeletal pain threshold and tolerance will be measured using an algometer, about trigger points on the identified muscles (rectus abdominis, quadratus lumborum, erector spinae, and tibialis anterior). A total of 40 women, aged 18-40, diagnosed with primary dysmenorrhea by a gynecologist, will be included in the study. The initial assessment of the participants will be conducted on their most painful days. Participants will be randomized into two groups: the myofascial release technique group (study group) and the placebo myofascial release technique group (control group). The interventions will be conducted over 10 sessions during one menstrual cycle, and all evaluations will be repeated after the treatment period. The study will be conducted as a double-blind trial, ensuring that both the evaluators and the patients are blind to the group assignments.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide,
  • Having regular menstruation in the last 6 months (28±7 days)
  • Those who had menstrual pain between 40 mm and 100 mm according to the Visual Analogue Scale (VAS) in the last 6 months

Exclusion criteria

  • Diagnosed with Secondary Dysmenorrhea,
  • Having given birth,
  • Those with serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes,
  • Undergoing urogynecological surgery,
  • Those who are pregnant or suspected of pregnancy,
  • Those who use analgesics or non-pharmacological agents other than NSAIDs for menstrual pain,
  • Those using intrauterine or oral contraceptives,
  • Those taking extra supplements such as magnesium, which may affect treatment

Treatment and study plan

Myofascial Release

Other

The myofascial release technique is a widely used manual therapy method characterized by low-load, prolonged mechanical forces applied to manipulate the myofascial complex, aiming to restore optimal length, alleviate pain, and improve function.

Sham-Myofascial Release

Other

The hands of the researcher applying the technique will be placed in the same areas as the myofascial release technique, with only the palms in light contact for the same duration. However, no intervention will be made to create any pressure or open the tissue barrier.

Primary outcomes

  1. Pain Pressure Threshold

    Time frame: Baseline (First menstruation cycle)

    Trigger points in specific muscles (rectus abdominis, paraspinal muscles, quadratus lumborum, gluteus maximus) will be determined. Then, it will be applied to the trigger points with the Baseline brand algometer in accordance with standard procedures and the pressure will be increased by 30 kPa/s.

  2. Pain Pressure Threshold

    Time frame: through study completion, an average of 3 months

    Trigger points in specific muscles (rectus abdominis, paraspinal muscles, quadratus lumborum, gluteus maximus) will be determined. Then, it will be applied to the trigger points with the Baseline brand algometer in accordance with standard procedures and the pressure will be increased by 30 kPa/s.

  3. Central Sensitization

    Time frame: Baseline (First menstruation cycle)

    Pain threshold will be measured with an algometer at a certain point of the tibialis muscle.

  4. Central Sensitization

    Time frame: through study completion, an average of 3 months

    Pain threshold will be measured with an algometer at a certain point of the tibialis muscle.

  5. Menstrual pain intensity

    Time frame: Baseline (First menstruation cycle)

    Menstrual pain intensity will be determined by a 10 cm Visual Analog Scale ranging from zero (no pain at all) to 10 (worst pain I have ever felt). Higher scores mean worse conditions. Participants will be asked to mark the severity of pain they felt in the first 3 days of their last menstrual bleeding on 3 separate lines.

  6. Menstrual pain intensity

    Time frame: through study completion, an average of 3 months

    Menstrual pain intensity will be determined by a 10 cm Visual Analog Scale ranging from zero (no pain at all) to 10 (worst pain I have ever felt). Higher scores mean worse conditions. Participants will be asked to mark the severity of pain they felt in the first 3 days of their last menstrual bleeding on 3 separate lines.

Secondary outcomes

  1. Menstrual Attitude

    Time frame: Baseline (First menstruation cycle)

    Menstrual Attitude Scale will be used to evaluate symptoms related to menstruation. High scores indicate a high awareness of menstruation.

  2. Menstrual Attitude

    Time frame: through study completion, an average of 3 months

    Menstrual Attitude Scale will be used to evaluate symptoms related to menstruation. High scores indicate a high awareness of menstruation.

  3. Health-related quality of life

    Time frame: Baseline (First menstruation cycle)

    Short Form (SF-36) will be used to evaluate individuals' general health-related quality of life. SF-36 is a 36-question survey that evaluates functionality and well-being and consists of 8 subscales. Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Higher scores indicate a better quality of life.

  4. Health-related quality of life

    Time frame: through study completion, an average of 3 months

    SF-36 will be used to evaluate individuals' general health-related quality of life. SF-36 is a 36-question survey that evaluates functionality and well-being and consists of 8 subscales. Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Higher scores indicate a better quality of life.

  5. Anxiety

    Time frame: Baseline (First menstruation cycle)

    State and Trait Anxiety Scale is a self-assessment inventory that evaluates anxiety and consists of 40 items.

  6. Anxiety

    Time frame: through study completion, an average of 3 months

    State and Trait Anxiety Scale is a self-assessment inventory that evaluates anxiety and consists of 40 items.

  7. The Body Awareness

    Time frame: Baseline (First menstruation cycle)

    The Body Awareness Questionnaire will be used to evaluate changes in individuals' body awareness. The questionnaire consists of 18 items and 4 subscales (predicting body reactions, sleep-wake cycle, predicting the onset of the disease, paying attention to changes in body processes).

  8. The Body Awareness

    Time frame: through study completion, an average of 3 months

    The Body Awareness Questionnaire will be used to evaluate changes in individuals' body awareness. The questionnaire consists of 18 items and 4 subscales (predicting body reactions, sleep-wake cycle, predicting the onset of the disease, paying attention to changes in body processes).

Study contacts

Contact information is provided by the study sponsor or research team.

Research Asisstant

CONTACT

[email protected]

+905535134631

Sponsors and collaborators

Lead sponsor

Gazi University

Other

Registry information

Official study title

Effect of Myofascial Release Technique on Central Sensitization, Myofascial Trigger Point and Menstrual Symptoms in Women With Primary Dysmenorrhea: Sham-Controlled, Randomized Double-Blind Study

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Jul 9, 2024
Registry last updated
Nov 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.